DR info

Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

Spinocerebellar degeneration and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
18	Spinocerebellar degeneration
13	Multiple sclerosis/Neuromyelitis optica
6	Parkinson disease
206	Fragile X syndrome
97	Ulcerative colitis
2	Amyotrophic lateral sclerosis
156	Rett syndrome
8	Huntington disease
17	Multiple system atrophy
3	Spinal muscular atrophy
5	Progressive supranuclear palsy
140	Dorabe syndrome
144	Lennox-Gastaut syndrome
205	Fragile X syndrome related disease
193	Prader-Willi syndrome
96	Crohn disease
46	Malignant rheumatoid arthritis
21	Mitochondrial disease
152	PCDH19 related syndrome
70	Spinal stenosis
84	Sarcoidosis
145	West syndrome
203	22q11.2 deletion syndrome
296	Biliary atresia
201	Angelman syndrome
98	Eosinophilic gastrointestinal disease
22	Moyamoya disease
158	Tuberous sclerosis
34	Neurofibromatosis
272	Fibrodysplasia ossificans progressiva
298	Hereditary pancreatitis
155	Acquired aphasia with convulsive disorder
36	Epidermolysis bullosa
231	Alpha-1-antitrypsin deficiency
75	Cushing disease
85	Idiopathic interstitial pneumonia
113	Muscular dystrophy
49	Systemic lupus erythematosus
78	Hypopituitarism
127	Frontotemporal lobar degeneration
120	Hereditary dystonia
215	Tetralogy of Fallot
4	Primary lateral sclerosis
65	Primary immunodeficiency
299	Cystic fibrosis
171	Wilson disease
179	Williams syndrome
235	Hypoparathyroidism
220	Rapidly progressive glomerulonephritis
30	Distal myopathy